Dipeptidyl peptidase I and granzyme A are coordinately expressed during CD8+ T cell development and differentiation

Christopher L. Mabee, Michael J. McGuire, Dwain L Thiele

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Dipeptidyl peptidase I (DPPI) is a granule protease that plays a requisite role in processing the proenzyme form of the CTL granule serine proteases (granzymes). This study assesses DPPI mRNA and enzyme expression during T lymphocyte ontogeny and CTL differentiation. The most immature CD3- CD4-CD8- thymocytes were found to express >40-fold higher levels of DPPI mRNA, although levels of DPPI enzymatic activity in CD3-CD4-CD8- thymocytes were only modestly higher than those seen for CD4+CD8+ or CD4+CD8- thymocytes. More mature CD8+CD4- thymocytes and CD8+ splenocytes expressed significantly higher levels of DPPI mRNA and enzymatic activity than CD4+CD8+ or CD4+CD8- thymocytes. Granzyme A mRNA expression was observed in DPPI expressing CD3-CD4-CD8- and CD8+CD4- thymocytes and was also observed in CD8+CD4- splenocytes; however, expression was not observed in CD4+CD8+ or CD4+CD8- thymocytes. Both DPPI mRNA and granzyme A mRNA expression in CD8+ T cells decreased to very low or undetectable levels during the first 48 h after allostimulation in MLCs. However, peak levels of both DPPI and granzyme A expression were observed later in the course of CD8+ T cell responses to alloantigen, with DPPI mRNA expression peaking on either day 3 or day 4 and granzyme A expression peaking at the end of a 5-day MLR. These data indicate that DPPI is expressed at all stages of T cell ontogeny and differentiation in which granzyme A mRNA is detected; consequently, DPPI appears to be available for the processing and activation of granzyme A during both CD8+ T cell development and differentiation.

Original languageEnglish (US)
Pages (from-to)5880-5885
Number of pages6
JournalJournal of Immunology
Volume160
Issue number12
StatePublished - Jun 15 1998

Fingerprint

Cathepsin C
Granzymes
Cell Differentiation
Thymocytes
T-Lymphocytes
Messenger RNA
Enzyme Precursors
Isoantigens
Serine Proteases

ASJC Scopus subject areas

  • Immunology

Cite this

Dipeptidyl peptidase I and granzyme A are coordinately expressed during CD8+ T cell development and differentiation. / Mabee, Christopher L.; McGuire, Michael J.; Thiele, Dwain L.

In: Journal of Immunology, Vol. 160, No. 12, 15.06.1998, p. 5880-5885.

Research output: Contribution to journalArticle

@article{ee1ba676bfe34ff28ee822945fd37ce0,
title = "Dipeptidyl peptidase I and granzyme A are coordinately expressed during CD8+ T cell development and differentiation",
abstract = "Dipeptidyl peptidase I (DPPI) is a granule protease that plays a requisite role in processing the proenzyme form of the CTL granule serine proteases (granzymes). This study assesses DPPI mRNA and enzyme expression during T lymphocyte ontogeny and CTL differentiation. The most immature CD3- CD4-CD8- thymocytes were found to express >40-fold higher levels of DPPI mRNA, although levels of DPPI enzymatic activity in CD3-CD4-CD8- thymocytes were only modestly higher than those seen for CD4+CD8+ or CD4+CD8- thymocytes. More mature CD8+CD4- thymocytes and CD8+ splenocytes expressed significantly higher levels of DPPI mRNA and enzymatic activity than CD4+CD8+ or CD4+CD8- thymocytes. Granzyme A mRNA expression was observed in DPPI expressing CD3-CD4-CD8- and CD8+CD4- thymocytes and was also observed in CD8+CD4- splenocytes; however, expression was not observed in CD4+CD8+ or CD4+CD8- thymocytes. Both DPPI mRNA and granzyme A mRNA expression in CD8+ T cells decreased to very low or undetectable levels during the first 48 h after allostimulation in MLCs. However, peak levels of both DPPI and granzyme A expression were observed later in the course of CD8+ T cell responses to alloantigen, with DPPI mRNA expression peaking on either day 3 or day 4 and granzyme A expression peaking at the end of a 5-day MLR. These data indicate that DPPI is expressed at all stages of T cell ontogeny and differentiation in which granzyme A mRNA is detected; consequently, DPPI appears to be available for the processing and activation of granzyme A during both CD8+ T cell development and differentiation.",
author = "Mabee, {Christopher L.} and McGuire, {Michael J.} and Thiele, {Dwain L}",
year = "1998",
month = "6",
day = "15",
language = "English (US)",
volume = "160",
pages = "5880--5885",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "12",

}

TY - JOUR

T1 - Dipeptidyl peptidase I and granzyme A are coordinately expressed during CD8+ T cell development and differentiation

AU - Mabee, Christopher L.

AU - McGuire, Michael J.

AU - Thiele, Dwain L

PY - 1998/6/15

Y1 - 1998/6/15

N2 - Dipeptidyl peptidase I (DPPI) is a granule protease that plays a requisite role in processing the proenzyme form of the CTL granule serine proteases (granzymes). This study assesses DPPI mRNA and enzyme expression during T lymphocyte ontogeny and CTL differentiation. The most immature CD3- CD4-CD8- thymocytes were found to express >40-fold higher levels of DPPI mRNA, although levels of DPPI enzymatic activity in CD3-CD4-CD8- thymocytes were only modestly higher than those seen for CD4+CD8+ or CD4+CD8- thymocytes. More mature CD8+CD4- thymocytes and CD8+ splenocytes expressed significantly higher levels of DPPI mRNA and enzymatic activity than CD4+CD8+ or CD4+CD8- thymocytes. Granzyme A mRNA expression was observed in DPPI expressing CD3-CD4-CD8- and CD8+CD4- thymocytes and was also observed in CD8+CD4- splenocytes; however, expression was not observed in CD4+CD8+ or CD4+CD8- thymocytes. Both DPPI mRNA and granzyme A mRNA expression in CD8+ T cells decreased to very low or undetectable levels during the first 48 h after allostimulation in MLCs. However, peak levels of both DPPI and granzyme A expression were observed later in the course of CD8+ T cell responses to alloantigen, with DPPI mRNA expression peaking on either day 3 or day 4 and granzyme A expression peaking at the end of a 5-day MLR. These data indicate that DPPI is expressed at all stages of T cell ontogeny and differentiation in which granzyme A mRNA is detected; consequently, DPPI appears to be available for the processing and activation of granzyme A during both CD8+ T cell development and differentiation.

AB - Dipeptidyl peptidase I (DPPI) is a granule protease that plays a requisite role in processing the proenzyme form of the CTL granule serine proteases (granzymes). This study assesses DPPI mRNA and enzyme expression during T lymphocyte ontogeny and CTL differentiation. The most immature CD3- CD4-CD8- thymocytes were found to express >40-fold higher levels of DPPI mRNA, although levels of DPPI enzymatic activity in CD3-CD4-CD8- thymocytes were only modestly higher than those seen for CD4+CD8+ or CD4+CD8- thymocytes. More mature CD8+CD4- thymocytes and CD8+ splenocytes expressed significantly higher levels of DPPI mRNA and enzymatic activity than CD4+CD8+ or CD4+CD8- thymocytes. Granzyme A mRNA expression was observed in DPPI expressing CD3-CD4-CD8- and CD8+CD4- thymocytes and was also observed in CD8+CD4- splenocytes; however, expression was not observed in CD4+CD8+ or CD4+CD8- thymocytes. Both DPPI mRNA and granzyme A mRNA expression in CD8+ T cells decreased to very low or undetectable levels during the first 48 h after allostimulation in MLCs. However, peak levels of both DPPI and granzyme A expression were observed later in the course of CD8+ T cell responses to alloantigen, with DPPI mRNA expression peaking on either day 3 or day 4 and granzyme A expression peaking at the end of a 5-day MLR. These data indicate that DPPI is expressed at all stages of T cell ontogeny and differentiation in which granzyme A mRNA is detected; consequently, DPPI appears to be available for the processing and activation of granzyme A during both CD8+ T cell development and differentiation.

UR - http://www.scopus.com/inward/record.url?scp=0032526606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032526606&partnerID=8YFLogxK

M3 - Article

C2 - 9637500

AN - SCOPUS:0032526606

VL - 160

SP - 5880

EP - 5885

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 12

ER -